EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 4

Ensembl ID : ENSPEMG00000019041
Gene Symbol: PSMD4
3 Cross references
289 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSPEMG00000007867
Gene Symbol: PSMD6
3 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSPEMG00000000353
Gene Symbol: PSMD7
3 Cross references
238 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSPEMG00000001149
Gene Symbol: PSMD8
3 Cross references
172 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSPEMG00000017614
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSPEMG00000000053
Gene Symbol: PRKCA
3 Cross references
289 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSPEMG00000001836
Gene Symbol: PRKCB
3 Cross references
284 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSPEMG00000020491
Gene Symbol: PRKCE
3 Cross references
315 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSPEMG00000021936
Gene Symbol: PRKCH
3 Cross references
237 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSPEMG00000009397
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase C, Delta

Ensembl ID : ENSPEMG00000017874
Gene Symbol: PRKCD
1 Cross references
280 Possible Orthologues:

Protein Kinase C, Gamma

Ensembl ID : ENSPEMG00000002232
Gene Symbol: PRKCG
1 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).